Table 1.
Baseline characteristics of study participants in intervention and control groups. Values are numbers (percentages) unless stated otherwise
| Characteristics | Intervention (n=45) | Control (n=48) |
|---|---|---|
| Mean (SD) age (years) | 56.6 (8.8) | 58.4 (8.8) |
| Women | 28 (62) | 27 (56) |
| Self identified ethnicity: | ||
| New Zealand European | 34 (76) | 42 (88) |
| Māori | 1 (2) | 2 (4) |
| Pacific Island | 3 (7) | 0 (0) |
| Other | 7 (16) | 4 (8) |
| Current smoker | 4 (9) | 3 (6) |
| Mean (SD) duration of diabetes (years) | 8.7 (6.4) | 9.0 (5.8) |
| Drug groups: | ||
| Oral hypoglycaemic agents only | 31 (69) | 34 (71) |
| Insulin only | 1 (2) | 0 (0) |
| Insulin and oral hypoglycaemic agent(s) | 13 (29) | 14 (29) |
| Lipid modifying drugs | 26 (58) | 31 (65) |
| Angiotensin converting enzyme inhibitor, angiotensin II receptor blocker, or both | 24 (53) | 30 (63) |
| Other antihypertensive agents | 14 (31) | 23 (48) |
| Aspirin | 17 (38) | 31 (65) |